Clinical Trial Update: A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated two topical doses of GW870086X against a positive control and placebo in atopic dermatitis; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GW870086X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2017-10-16